Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Riociguat use in sickle cell related chronic thromboembolic pulmonary hypertension: A case series.

Weir NA, Conrey A, Lewis D, Mehari A.

Pulm Circ. 2018 Oct-Dec;8(4):2045894018791802. doi: 10.1177/2045894018791802. Epub 2018 Jul 23.

2.

Abnormal Ventilation-Perfusion Scan Is Associated with Pulmonary Hypertension in Sickle Cell Adults.

Mehari A, Igbineweka N, Allen D, Nichols J, Thein SL, Weir NA.

J Nucl Med. 2019 Jan;60(1):86-92. doi: 10.2967/jnumed.118.211466. Epub 2018 Jun 7.

PMID:
29880507
3.

Spironolactone-induced degradation of the TFIIH core complex XPB subunit suppresses NF-κB and AP-1 signalling.

Elinoff JM, Chen LY, Dougherty EJ, Awad KS, Wang S, Biancotto A, Siddiqui AH, Weir NA, Cai R, Sun J, Preston IR, Solomon MA, Danner RL.

Cardiovasc Res. 2018 Jan 1;114(1):65-76. doi: 10.1093/cvr/cvx198.

4.

High density lipoproteins and type 2 inflammatory biomarkers are negatively correlated in atopic asthmatics.

Barochia AV, Gordon EM, Kaler M, Cuento RA, Theard P, Figueroa DM, Yao X, Weir NA, Sampson ML, Stylianou M, Choy DF, Holweg CTJ, Remaley AT, Levine SJ.

J Lipid Res. 2017 Aug;58(8):1713-1721. doi: 10.1194/jlr.P077776. Epub 2017 Jun 27.

5.

A randomized, placebo-controlled, double-blinded, crossover trial of pioglitazone for severe asthma.

Kaler M, Barochia AV, Weir NA, Cuento RA, Stylianou M, Roth MJ, Filie AC, Vaughey EC, Nathan SD, Levine SJ.

J Allergy Clin Immunol. 2017 Dec;140(6):1716-1718. doi: 10.1016/j.jaci.2017.05.033. Epub 2017 Jun 15. No abstract available.

6.

Prostacyclin-analog therapy in sickle cell pulmonary hypertension.

Weir NA, Saiyed R, Alam S, Conrey A, Desai HD, George MP, Keeley JH, Klings ES, Mehari A, Taylor JG 6th, Minniti CP, Kato GJ.

Haematologica. 2017 May;102(5):e163-e165. doi: 10.3324/haematol.2015.131227. Epub 2017 Jan 25. No abstract available.

7.

Reversal of pre-capillary pulmonary hypertension in a patient with sickle cell anemia who underwent haploidentical peripheral blood stem cell transplantation.

Pittman C, Hsieh MM, Coles W, Tisdale JF, Weir NA, Fitzhugh CD.

Bone Marrow Transplant. 2017 Apr;52(4):641-642. doi: 10.1038/bmt.2016.335. Epub 2017 Jan 9. No abstract available.

8.

Pulmonary artery size as a predictor of outcomes in idiopathic pulmonary fibrosis.

Shin S, King CS, Puri N, Shlobin OA, Brown AW, Ahmad S, Weir NA, Nathan SD.

Eur Respir J. 2016 May;47(5):1445-51. doi: 10.1183/13993003.01532-2015. Epub 2016 Feb 4.

9.

Changes in fatigability following intense aerobic exercise training in patients with interstitial lung disease.

Keyser RE, Christensen EJ, Chin LM, Woolstenhulme JG, Drinkard B, Quinn A, Connors G, Weir NA, Nathan SD, Chan LE.

Respir Med. 2015 Apr;109(4):517-25. doi: 10.1016/j.rmed.2015.01.021. Epub 2015 Feb 7.

10.

Serum apolipoprotein A-I and large high-density lipoprotein particles are positively correlated with FEV1 in atopic asthma.

Barochia AV, Kaler M, Cuento RA, Gordon EM, Weir NA, Sampson M, Fontana JR, MacDonald S, Moss J, Manganiello V, Remaley AT, Levine SJ.

Am J Respir Crit Care Med. 2015 May 1;191(9):990-1000. doi: 10.1164/rccm.201411-1990OC.

11.

Cardiorespiratory function before and after aerobic exercise training in patients with interstitial lung disease.

Keyser RE, Woolstenhulme JG, Chin LM, Nathan SD, Weir NA, Connors G, Drinkard B, Lamberti J, Chan L.

J Cardiopulm Rehabil Prev. 2015 Jan-Feb;35(1):47-55. doi: 10.1097/HCR.0000000000000083.

12.

Outcomes after hospitalization in idiopathic pulmonary fibrosis: a cohort study.

Brown AW, Fischer CP, Shlobin OA, Buhr RG, Ahmad S, Weir NA, Nathan SD.

Chest. 2015 Jan;147(1):173-179. doi: 10.1378/chest.13-2424.

PMID:
25188694
13.

Response.

Nathan SD, Brown AW, Weir NA.

Chest. 2014 Jun;145(6):1440-1441. doi: 10.1378/chest.14-0720. No abstract available.

14.

Gender and the association of smoking with sleep quantity and quality in American adults.

Mehari A, Weir NA, Gillum RF.

Women Health. 2014;54(1):1-14. doi: 10.1080/03630242.2013.858097.

PMID:
24261545
15.

The influence of alternative instruction on 6-min walk test distance.

Weir NA, Brown AW, Shlobin OA, Smith MA, Reffett T, Battle E, Ahmad S, Nathan SD.

Chest. 2013 Dec;144(6):1900-1905. doi: 10.1378/chest.13-0287.

PMID:
23975232
16.

Plasma phospholipid trans fatty acids and risk of heart failure.

Tokede OA, Petrone AB, Hanson NQ, Tsai MY, Weir NA, Glynn RJ, Gaziano JM, Djoussé L.

Am J Clin Nutr. 2013 Apr;97(4):698-705. doi: 10.3945/ajcn.112.050120. Epub 2013 Feb 27.

17.

Benefits of intensive treadmill exercise training on cardiorespiratory function and quality of life in patients with pulmonary hypertension.

Chan L, Chin LMK, Kennedy M, Woolstenhulme JG, Nathan SD, Weinstein AA, Connors G, Weir NA, Drinkard B, Lamberti J, Keyser RE.

Chest. 2013 Feb 1;143(2):333-343. doi: 10.1378/chest.12-0993.

18.

Achieving symptom control in patients with moderate asthma.

Weir NA, Levine SJ.

Clin Med Insights Circ Respir Pulm Med. 2012;6:1-11. doi: 10.4137/CCRPM.S5100. Epub 2011 Dec 7.

19.

Degradation of poly-L-lactide. Part 2: increased temperature accelerated degradation.

Weir NA, Buchanan FJ, Orr JF, Farrar DF, Dickson GR.

Proc Inst Mech Eng H. 2004;218(5):321-30.

PMID:
15532997
20.

Degradation of poly-L-lactide. Part 1: in vitro and in vivo physiological temperature degradation.

Weir NA, Buchanan FJ, Orr JF, Dickson GR.

Proc Inst Mech Eng H. 2004;218(5):307-19.

PMID:
15532996
21.

Processing, annealing and sterilisation of poly-L-lactide.

Weir NA, Buchanan FJ, Orr JF, Farrar DF, Boyd A.

Biomaterials. 2004 Aug;25(18):3939-49.

PMID:
15046884
22.

A case of pleural mesothelioma with effusive-constrictive pericarditis.

Weir NA, Gerstenhaber B.

Yale J Biol Med. 2001 May-Jun;74(3):159-63. No abstract available.

Supplemental Content

Support Center